Adiponectin multimers, body weight and markers of cardiovascular risk in adolescence: Northern Ireland Young Hearts Project

International Journal of Obesity

Volumn 37, Issue 9, 2013, Pages 1247-1253

  McCourt, H J ^a   Hunter, S J ^b   Cardwell, C R ^c   Young, I S ^a   Murray, L J ^c   Boreham, C A ^d   McEneny, J ^a   Woodside, J V ^a   McKinley, M C ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Adiponectin; Adolescents; Body weight; Cardiovascular disease

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILDHOOD OBESITY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPONECTIN; ADOLESCENT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; NORTHERN IRELAND; OBESITY; PHENOTYPE; POLYMERS; QUESTIONNAIRES; RISK FACTORS; SMOKING; THINNESS; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 84883778542     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.214     Document Type: Article

References (52)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556. (Pubitemid 38766330)
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332.
3. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J 2009; 73: 608-614.
4. Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert MO et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005; 54: 2712-2719. (Pubitemid 41233594)
5. Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS. Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-Molecular-Weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 2008; 87: 347-353. (Pubitemid 351226070)
6. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004; 89: 3790-3794. (Pubitemid 39071473)
7. Elloumi M, Ben Ounis O, Makni E, Van Praagh E, Tabka Z, Lac G. Effect of individualized weight-Loss programmes on adiponectin, leptin and resistin levels in obese adolescent boys. Acta Paediatr 2009; 98: 1487-1493.
8. Zhu N, Pankow JS, Ballantyne CM, Couper D, Hoogeveen RC, Pereira M et al. Highmolecular-Weight adiponectin and the risk of type diabetes in the ARIC Study. J Clin Endocrinol Metab 2010; 95: 5097-5104.
9. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM et al. Adiponectin and coronary heart disease: A prospective study and meta-Analysis. Circulation 2006; 114: 623-629. (Pubitemid 44252303)
10. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A et al. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 2008; 38: 827-834.
11. Bluher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S et al. Total and high-Molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: Comparative evaluation of three assays. Diabetes Care 2007; 30: 280-285. (Pubitemid 46198331)
12. Rizza S, Gigli F, Galli A, Micchelini B, Lauro D, Lauro R et al. Adiponectin isoforms in elderly patients with or without coronary artery disease. J Am Geriatr Soc 2010; 58: 702-706.
13. Baumann M, Von Eynatten M, Dan L, Richart T, Kouznetsova T, Heemann U et al. Altered molecular weight forms of adiponectin in hypertension. J Clin Hypertens 2009; 11: 11-16.
14. Yiannikouris F, Gupte M, Putnam K, Cassis L. Adipokines and blood pressure control. Curr Opin Nephrol Hypertens 2010; 19: 195-200.
15. Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Adiponectin: From obesity to cardiovascular disease. Obes Rev 2009; 10: 269-279.
16. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55: 249-259. (Pubitemid 43343322)
17. Salani B, Briatore L, Andraghetti G, Adami GF, Maggi D, Cordera R. High-Molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity 2006; 14: 1511-1514. (Pubitemid 46214817)
18. Fisher FF, Trujillo ME, Hanif W, Barnett AH, McTernan PG, Scherer PE et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 2005; 48: 1084-1087. (Pubitemid 40909642)
19. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H et al. Measurement of the high-Molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006; 29: 1357-1362. (Pubitemid 44125935)
20. Wang W, Xing W, Zhang H, Ding M, Shang L, Lau WB et al. Reduced high molecular weight adiponectin is an independent risk factor of cardiovascular lesions in hypercholesterolemic patients. Clin Endocrinol (e-Pub ahead of print May 2012; doi:10.1111/j.1365-2265.2012.04444.x.).
21. Ong KK, Frystyk J, Flyvbjerg A, Petry CJ, Ness A, Dunger DB. Sex-Discordant associations with adiponectin levels and lipid profiles in children. Diabetes 2006; 55: 1337-1341. (Pubitemid 44195372)
22. Jeffery AN, Murphy MJ, Metcalf BS, Hosking J, Voss LD, English P et al. Adiponectin in childhood. Int J Pediatr Obes 2008; 3: 130-140. (Pubitemid 352015837)
23. Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High Molecular Weight, Rather than Total, Adiponectin Levels Better Reflect Metabolic Abnormalities Associated with Childhood Obesity. J Clin Endocrinol Metab 2006; 91: 5113-5116. (Pubitemid 44917359)
24. Mangge H, Almer G, Haj-Yahya S, Pilz S, Gasser R, Moller R et al. Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity 2008; 16: 2578-2584.
25. Murdolo G, Nowotny B, Celi F, Donati MB, Bini V, Papi F et al. Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: A population-Based survey in prepubertal school children. PLoS ONE 2011; 6: E17264.
26. Nakatani H, Hirose H, Yamamoto Y, Saito I, Itoh H. Significance of leptin and highmolecular weight adiponectin in the general population of Japanese male adolescents. Metab Clin Exp 2008; 57: 157-162.
27. Boreham C, Savage JM, Primrose D, Cran G, Strain J. Coronary risk factors in schoolchildren. Arch Dis Child 1993; 68: 182-186. (Pubitemid 23066998)
28. Cole TJ. A chart to link child centiles of body mass index, weight and height. Eur J Clin Nutr 2002; 56: 1194-1199. (Pubitemid 36124408)
29. McGartland CP, Robson PJ, Murray LJ, Cran GW, Savage MJ, Watkins DC et al. Fruit and vegetable consumption and bone mineral density: The Northern Ireland Young Hearts Project. Am J Clin Nutr 2004; 80: 1019-1023.
30. Watkins DC, Murray LJ, McCarron P, Boreham CA, Cran GW, Young IS et al. Tenyear trends for fatness in Northern Irish adolescents: The Young Hearts Projects-Repeat cross-Sectional study. Int J Obes 2005; 29: 579-585. (Pubitemid 40769478)
31. Tanner JM. Growth at Adolescence. Blackwell Scientific Publications: Oxford, 1962.
32. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men' Circulation 2000; 102: 179-184. (Pubitemid 30451774)
33. Esmaillzadeh A, Mirmiran P, Azizi F. Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr 2006; 83: 36-46. (Pubitemid 44699232)
34. Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K. Adiponectin, insulin resistance, and C-Reactive protein in postpubertal Asian Indian adolescents. Metab Clin Exp 2004; 53: 1336-1341. (Pubitemid 39222096)
35. Valle M, Martos R, Gascon F, Canete R, Zafra MA, Morales R. Low-Grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 2005; 31: 55-62. (Pubitemid 40327593)
36. Mangge H, Almer G, Haj-Yahya S, Grandits N, Gasser R, Pilz S et al. Nuchal thickness of subcutaneous adipose tissue is tightly assocaited with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis 2009; 203: 277-283.
37. Liu Y, Retnakaran R, Hanley A, Tungtrongchitr R, Shaw C, Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in thai subjects. J Clin Endocrinol Metab 2007; 92: 4313-4318. (Pubitemid 350074750)
38. Martos-Moreno GA, Barrios V, Martinez G, Hawkins F, Argente J. Effect of Weight Loss on High-Molecular Weight Adiponectin in Obese Children. Obesity 2010; 18: 2288-2294.
39. Araki S, Dobashi K, Yamamoto Y, Asayama K, Kusuhara K. Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children. Eur J Pediatr 2010; 169: 965-970.
40. Polak J, Kovacova Z, Jacek M, Klimcakova E, Kovacikova M, Vitkova M et al. An increase in plasma adiponectin multimeric complexes follows hypocaloric dietinduced weight loss in obese and overweight pre-Menopausal women. Clin Sci 2007; 112: 557-565. (Pubitemid 46849546)
41. Schober F, Neumeier M, Weigert J, Wurm S, Wanninger J, Schaffler A et al. Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 2007; 361: 968-973. (Pubitemid 47259030)
42. Lara-Castro C, Doud EC, Tapia PC, Munoz AJ, Fernandez JR, Hunter GR et al. Adiponectin multimers and metabolic syndrome traits: Relative adiponectin resistance in African Americans. Obesity 2008; 16: 2616-2623.
43. Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolic syndrome: Mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007; 18: 263-270. (Pubitemid 46743049)
44. Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome' Diabetes Obes Metab 2007; 9: 246-258. (Pubitemid 46502042)
45. Choi KM, Yannakoulia M, Park MS, Cho GJ, Kim JH, Lee SH et al. Serum adipocyte fatty acid-Binding protein, retinol-Binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: A 3-Y prospective cohort study. Am J Clin Nutr 2011; 93: 19-26.
46. Morrison JA, Glueck CJ, Daniels S, Wang P, Horn P, Stroop D. Paradoxically high adiponectin and the healthy obese phenotype in obese black and white 16-Yearold girls. Transl Res 2010; 156: 302-308.
47. Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Cruz-Bautista I, Arellano-Campos O et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol 2010; 9: 26.
48. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005; 54: 333-339.
49. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type diabetes: Differential regulation from nondiabetic subjects. Diabetes 2007; 56: 2174-2177. (Pubitemid 47195840)
50. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. (Pubitemid 32472900)
51. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K et al. Correlation of the adipocyte-Derived protein adiponectin with insulin resistance index and serum high-Density lipoprotein-Cholesterol, independent of body mass index, in the Japanese population. Clin Sci 2002; 103: 137-142.
52. Yoon SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho ER et al. The association between adiponectin and diabetes in the Korean population. Metab Clin Exp 2008; 57: 853-857. (Pubitemid 351697916)